Selenozyme is a unique world-wide provider of recombinant selenoproteins for customers in academic research, pharmaceutical industry and other fields of biotechnology. Our cutting-edge technology, resulting from over 30 years of research at Karolinska Institutet, uses bacteria instead of mammalian extract, making the production cost lower, more ethical and more effective. Therefore, we are theoretically able to produce any of the 837 selenoproteins identified in nature, or any synthetic selenocysteine-containing proteins on demand. Do not hesitate to get in touch with us and let us know your needs or questions in the selenoprotein area!